S7 Ep45: Sauter and Hill Talk Through CAR T Cell Sequencing and Access in Lymphomas
S7 Ep44: FDA Approval Insights: Futibatinib in FGFR2-Positive Cholangiocarcinoma
S7 Ep43: Thymic Cancer Experts Discuss the Latest Data, Need for More Research Funding
S7 Ep42: Mikhael and Cole Share Insights on Culturally Relevant Myeloma Care
S7 Ep41: FDA Approval Insights: Sodium Thiosulfate in Cisplatin-Treated Pediatric Solid Tumors
S7 Ep40: Leukemia Experts Discuss Early Career Growth, Mentorship, and Gender Bias in Academia
S7 Ep39: Community Perspectives on Integrating and Interpreting Molecular Testing Results in NSCLC
S7 Ep38: FDA Approval Insights: Selpercatinib in RET Fusion–Positive Solid Tumors
S7 Ep37: Brentjens on the Next Chapter of CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma
S7 Ep36: Velcheti Discusses Mobile Telehealth-Based Research to Close Cancer Care Gaps
S7 Ep35: FDA Approval Insights: Durvalumab Plus Gemcitabine and Cisplatin in Biliary Tract Cancer
S7 Ep34: Shepard Discusses Symptoms, Management, and Future Directions in Desmoid Tumors
S7 Ep33: Deol on the Importance of a Well-Rounded Fellowship Experience
S7 Ep32: Patel Provides Insight Into Post-Transplant Complications in Myeloid Disorders
S7 Ep31: FDA Approval Insights: Pemigatinib in FGFR1-Rearranged Myeloid/Lymphoid Neoplasms
S7 Ep30: Leal Sheds Light on Symptoms and Treatment of Lambert-Eaton Myasthenic Syndrome
S7 Ep29: Elamin Elaborates on Poziotinib in EGFR Exon 20–Mutant NSCLC
S7 Ep28: Chen Discusses Diagnosis, Management, and Disparities in Cutaneous T-cell Lymphoma
S7 Ep27: FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Low Unresectable or Metastatic Breast Cancer
S7 Ep27: Iams and Shah Break Down Lambert-Eaton Myasthenic Syndrome in SCLC and Other Neuroendocrine Cancers
S7 Ep26: Bekaii-Saab, George, and von Mehren Discuss Pivotal Findings in GIST, TGCT, and RAS/RAF–Mutated Solid Tumors
S7 Ep25: FDA Approval Insights: Trastuzumab Deruxtecan in HER2-Mutant NSCLC
S7 Ep24: Petrylak Provides Insight Into Testing, Multidisciplinary Management in Prostate and Bladder Cancer
S7 Ep24: Goldberg and Sussman Dissect Disparities in Gastric Cancer Mortality Rates
S7 Ep23: FDA Approval Insights: Darolutamide Plus Docetaxel for Metastatic Hormone-Sensitive Prostate Cancer
S7 Ep22: Katz Considers the Role of Neoadjuvant Chemoradiation in Borderline Resectable Pancreatic Cancer
S7 Ep21: Leukemia Experts Reflect on Defining Moments as Women in the Field
S7 Ep20: Gradishar Stresses the Importance of Accurately Defining Breast Cancer Subtypes
S7 Ep19: Research Reflections: Subbiah Reviews Striking ASCO 2022 Data Across Oncology
S7 Ep18: FDA Approval Insights: Liso-Cel in Second-Line Relapsed/Refractory LBCL
S7 Ep17: Wagner Weighs In On Research and Development in Angiosarcoma
S7 Ep16: FDA Approval Insights: Dabrafenib Plus Trametinib for BRAF V600E–Mutated Unresectable or Metastatic Solid Tumors
S7 Ep15: Monk Recaps Benefit of Rucaparib Maintenance Therapy in Advanced Ovarian Cancer
S7 Ep14: Jain Discusses the Driving Forces of Gender Inequities in Medicine
S7 Ep13: Spiess Shares the Importance of Comprehensive, Multidisciplinary Care in Penile Cancer
S7 Ep12: Research Reflections: Tarantino Talks Through the Implications of ASCO 2022 Data in Breast Cancer
S7 Ep11: Duma Discusses the Unique Challenges of Women With Lung Cancer (Continued)
S7 Ep10: Duma Discusses the Unique Challenges of Women With Lung Cancer
S7 Ep9: Leukemia Pioneers Chronicle Career Experiences and Milestones
S7 Ep8: Khan Casts Light on Disparities in Surgical Care of GI Tract Cancer
S7 Ep7: Wise Summarizes Survival Data From ARASENS and PEACE-1 in Prostate Cancer
S7 Ep6: Lee Lays Out Treatment Developments in Non–Clear Cell RCC
S7 Ep5: Ueno Underscores the Importance of Accurate Diagnoses and Novel Treatments in IBC
S7 Ep4: Hua Highlights Innovative Research With Immunotherapy in NETs
S7 Ep3: Jefferson Faculty Highlight COVID-19-Induced Disparities in Older Patients With Cancer
S7 Ep2: Abid Accounts for the Efficacy of a Third SARS-CoV-2 Vaccine Among Transplant, CAR T-Cell, and BiTE Recipients
S7 Ep1: Karmanos Faculty Share Experiences and Career Insights as Women in Oncology
S6 Ep50: Tarantino Previews Exciting Research in HER2-Low Breast Cancer
S6 Ep49: Taylor Provides Insight Into Pirtobrutinib Resistance in CLL
S6 Ep48: Pro Presents Interim Results of PRIMO in Peripheral T-Cell Lymphoma
next page